Skip to Main Content

Paper Details

Clinical and molecular characterization of HER2 amplified-pancreatic cancer.
Genome Med
87
2013
HER2, HER2 locus, HER2-amplified cancers, PDAC, Pancreatic cancer, breast and gastric cancer, cancer, malignancies, pancreatic cancer, pancreatic ductal adenocarcinoma, patient, patients
Author NameAffiliation
Nicola WaddellInstitute for Molecular Bioscience, University of Queensland
Nicola WaddellInstitute for Molecular Bioscience, University of Queensland
Mark J CowleyKinghorn Cancer Centre and Garvan Institute of Medical Research, Australia St Vincent's Clinical School, University of New South Wales
Ann-Marie PatchInstitute for Molecular Bioscience, University of Queensland
Ann-Marie PatchInstitute for Molecular Bioscience, University of Queensland
Katia NonesInstitute for Molecular Bioscience, University of Queensland
Katia NonesInstitute for Molecular Bioscience, University of Queensland
Amber L JohnsKinghorn Cancer Centre and Garvan Institute of Medical Research
Karin S KassahnInstitute for Molecular Bioscience, University of Queensland
John V PearsonInstitute for Molecular Bioscience, University of Queensland
John V PearsonInstitute for Molecular Bioscience, University of Queensland
Adrienne MoreySt Vincent's Hospital
Adrienne MoreySt Vincent's Hospital
Sean M GrimmondInstitute for Molecular Bioscience, University of Queensland, Australia Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow
Sean M GrimmondInstitute for Molecular Bioscience, University of Queensland, Australia Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow
  • 1 - 15

Datasets